Bvf Inc Calliditas Therapeutics Ab Transaction History
Bvf Inc
- $3.27 Billion
- Q2 2024
A detailed history of Bvf Inc transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Bvf Inc holds 750,000 shares of CALT stock, worth $30 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
750,000
Previous 750,000
-0.0%
Holding current value
$30 Million
Previous $15.8 Million
85.58%
% of portfolio
0.89%
Previous 0.47%
Shares
1 transactions
Others Institutions Holding CALT
# of Institutions
23Shares Held
843KCall Options Held
8.5KPut Options Held
26.6K-
Ironwood Investment Management LLC Boston, MA25.6KShares$1.03 Million0.56% of portfolio
-
Optiver Holding B.V. Amsterdam, P722.3KShares$893,4400.02% of portfolio
-
Crossmark Global Holdings, Inc.16.1KShares$644,6800.01% of portfolio
-
Ubs Group Ag10.8KShares$430,2400.0% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16KShares$240,0000.2% of portfolio
About Calliditas Therapeutics AB
- Ticker CALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,624,800
- Market Cap $1.06B
- Description
- Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...